Baxter International Inc.

NYSE:BAX

Medical - Instruments & Supplies

Healthcare
$26.16 -5.23%

-$1.07 today

Market cap
$13.53B
Beta
0.64
P/E (TTM)
-9.1
EPS (TTM)
-$2.13
Dividend yield
1.03%
52W Low $15.73High $31.76

Volume 4.01M

Average 7.62M

BAX Other Financing Activities

Financing cash flows not reported separately.

Baxter International Inc.NYSE: BAX

Other Financing Activities · Q2 FY2026 · quarter ended Jun 2026

Other financing activities growth accelerates

Q2 FY2026 other financing activities of $34M (cash outflow) rose 3300.0% year over year, ahead of the +176.6% change in trailing-twelve-month other financing activities. Sequentially, it rose 142.9% from the prior quarter. Over 3 fiscal years it compounded at +20.6% a year.

Context

  • Other financing activities amounted to 1.0% of revenue in FY2025, up 0.7 pp from a year earlier.
  • Other financing activities grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +3300.0% holds above the trailing-twelve-month pace of +176.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$34M+142.9% QoQ
Last fiscal yearDec 2025
-$107M+245.2% YoY
LTMJun 2026
-$130M+176.6% YoY
Other Financing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3300.0%——
1 year+245.2%——
3-year CAGR+20.6%——
5-year CAGR——
10-year CAGR——

Other Financing Activities history

USD · from the cash flow

Latest · FY2025
(107M) USD
Year-over-year change
-245.2%

Other Financing Activities vs competitors

How BAX compares with its peers on the latest reported figures

  • Peers report in different currencies, so other financing activities is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +176.6% is the 2nd highest of 5, against a peer median of -13.4%.
  • Other financing activities amounts to 1.1% of revenue for BAX, versus a peer median of 3.5%.
BAX Competitors
Other Financing Activities for BAX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DVADaVita Inc.LTM Jun 2026$1.1B USD+186.9%+4.7%7.9%
FMSFresenius Medical Care AG & Co. KGaALTM Jun 2026€1.08B EUR+69.8%+124.5%5.6%
BAXBaxter International Inc.LTM Jun 2026$130M USD+176.6%+20.6%1.1%
ICUIICU Medical, Inc.LTM Jun 2026$30.14M USD-7692.7%—1.4%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$197K USD-96.6%—0.1%
Peer median (excluding BAX) —-13.4%+64.6%3.5%

Competitors are the stored peer set for BAX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income1.03B(3.11B)181M(326M)(957M)
Depreciation & Amortization867M1.07B984M997M981M
Deferred Income Tax(161M)(260M)(256M)(262M)77M
Stock-Based Compensation146M140M115M114M117M
Change in Working Capital(57M)(606M)161M(236M)(108M)
Accounts Receivables(170M)(48M)(38M)(35M)(132M)
Inventory(27M)(198M)(128M)(201M)(119M)
Accounts Payables105M(67M)92M112M3M
Other Working Capital35M(293M)235M(112M)140M
Other Non-Cash Items394M3.98B541M732M735M
Operating Cash Flow2.22B1.21B1.73B1.02B845M
Capital Expenditures(691M)(635M)(436M)(460M)(522M)
Acquisitions (Net)(10.5B)(263M)(6M)00
Purchases of Investments00000
Sales of Investments00034M0
Other Investing Activities(7M)(33M)3.66B(200M)3.35B
Investing Cash Flow(11.2B)(931M)3.21B(626M)2.84B
Debt Repayment9.33B(899M)(2.94B)(531M)(3.79B)
Common Stock Issued187M127M95M71M30M
Common Stock Repurchased(600M)(32M)000
Dividends Paid(530M)(573M)(586M)(590M)(348M)
Other Financing Activities(138M)(61M)(63M)(31M)(107M)
Financing Cash Flow8.25B(1.44B)(3.49B)(1.08B)(4.22B)
Effect of Forex Changes(47M)(76M)26M(96M)84M
Net Change in Cash(780M)(1.23B)1.48B(784M)(446M)
Free Cash Flow1.53B576M1.29B559M323M

Baxter International Inc.

NYSE:BAX

Intrinsic Alpha fair value

Locked

Current Price

$26.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.